glp-1 drug market size Pharma Giants Bet on Next-Generation Treatments to Sustain Growth GLP-1 Agonists Weight Loss Drugs
Description
No other approved or late-stage investigational compound does this
In cases where the medication cannot be withheld, patients can either have a gastric ultrasound to evaluate residual gastric volume, or they can be assumed to have a full stomach
Circulation 2024;150:1288-98.ArticlePubMed 113
GLP-1 Receptor Agonist Market Size and Trends Forecast: 2026 - 2033 GLP-1 receptor agonist market is estimated to be valued at USD 31.71 Bn in 2026 and is expected to reach USD 72.33 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033
The gastrointestinal effects of allulose are dose-dependent and vary considerably between individuals
